Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.75 USD | -0.57% | +6.06% | +209.73% |
May. 09 | Earnings Flash (NKTR) NEKTAR THERAPEUTICS Reports Q1 Revenue $21.6M, vs. Street Est of $15.3M | MT |
May. 09 | Transcript : Nektar Therapeutics, Q1 2024 Earnings Call, May 09, 2024 |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+209.73% | 321M | |
+29.98% | 682B | |
+31.84% | 586B | |
-3.52% | 364B | |
+18.59% | 327B | |
+4.07% | 285B | |
+16.92% | 240B | |
+10.02% | 209B | |
-8.26% | 203B | |
+7.09% | 165B |
- Stock Market
- Equities
- NKTR Stock
- News Nektar Therapeutics
- Transcript : Nektar Therapeutics Presents at Goldman Sachs 44th Annual Global Healthcare Conference, Jun-14-2023 01